Xencor (XNCR) FCF Margin Growth (1y) (2014 - 2026)
Xencor (XNCR) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -145,706.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -145,706.00 |
| Dec 31, 2025 | -8,962.00 |
| Sep 30, 2025 | 1,768.00 |
| Jun 30, 2025 | 21,010.00 |
| Mar 31, 2025 | 30,230.00 |
| Dec 31, 2024 | -13,125.00 |
| Sep 30, 2024 | -11,443.00 |
| Jun 30, 2024 | -20,195.00 |
| Mar 31, 2024 | -13,838.00 |
| Dec 31, 2023 | 19,287.00 |
| Sep 30, 2023 | 501.00 |
| Jun 30, 2023 | -19,810.00 |
| Mar 31, 2023 | -22,224.00 |
| Dec 31, 2022 | -19,519.00 |
| Sep 30, 2022 | 15,633.00 |
| Jun 30, 2022 | 12,338.00 |
| Mar 31, 2022 | 9,823.00 |
| Dec 31, 2021 | 272.00 |
| Sep 30, 2021 | -18,802.00 |
| Jun 30, 2021 | 19,854.00 |